PLASTOMICS INC.

ST. LOUIS, MO · Founded 2017 · Agritech · Private

Chloroplast transformation platform for engineering corn with multiple trait genes

Claim this profile

Follows are private to you and power your alerts

Updated · plastomics.com

Sector
Agritech
Headquarters
ST. LOUIS, MO
Founded
2017
Latest Form D
$7.1M, Dec 2021
Total capital
$11.4M
Federal grants
$225K
1 award · 2020
Rank in peer group#8 of 11
Private capital raised
$11.2M
3 Form D · last Dec 2021
58 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
13 pending

Capital timeline

2018201920202021FEDERAL ↑EQUITY ↓Cumulative $11.4M$225K1st Form D$934K2nd Form D$3.2M
2018201920202021FEDERAL ↑EQUITY ↓Cumulative $11.4M$225K1st Form D$934K2nd Form D$3.2M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$7.1M
  • Private capital raisedForm D · SEC · 2nd filing$3.2M
  • Federal grantNSF · Phase I · SBIR Phase I: Creating a Master Transformation Recipient Line for Chloroplast Engineering of Maize$225K
  • Private capital raisedForm D · SEC · 1st filing$934K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 11 peers

Line = median

Agritech · Platform

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Jeffrey StaubResearcherExecutive Officer, DirectorLinked by $225K in grants as PI
  • Brian ClevingerDirectorNamed in SEC Form D filings
  • Charles BoltenDirectorNamed in SEC Form D filings
  • Dave DuncanDirectorNamed in SEC Form D filings
  • Elizabeth GallegosExecutive OfficerNamed in SEC Form D filings
  • Gallegos ElizabethExecutive OfficerNamed in SEC Form D filings
Show all 10 people
  • John PeryamDirectorNamed in SEC Form D filings
  • Martha SchlicherExecutive Officer, DirectorNamed in SEC Form D filings
  • Sharon BerberichExecutive Officer, DirectorNamed in SEC Form D filings
  • Steve WelkerDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 13
  • PendingPlastid Transformation By Complementation Of Plastid MutationsUSPTOApplication 19311616
  • PendingPlastid-transgene-encoded nuclear gene silencingUSPTOApplication 18142777
  • PendingPlastid-transgene-encoded nuclear gene silencingUSPTOApplication 18108996
Show all 13 patent records
  • Plastid Transformation By Complementation Of Plastid MutationsMay 14, 2026 · Application 19311616Pending
  • Plastid-transgene-encoded nuclear gene silencingFeb 29, 2024 · Application 18142777Pending
  • Plastid-transgene-encoded nuclear gene silencingOct 26, 2023 · Application 18108996Pending
  • Plastid Transformation By Complementation Of Nuclear MutationsOct 5, 2023 · Application 18180488Pending
  • Plastid Transformation By Complementation Of Plastid MutationsAug 31, 2023 · Application 18180399Pending
  • Plastid Transformation By Complementation Of Plastid MutationsApplication 63180766Pending
  • Plastid Transformation By Complementation Of Nuclear MutationsApplication 63180783Pending
  • Plastid Transformation By Complementation Of Plastid MutationsApplication 62706760Pending
  • Plastid Transformation By Complementation Of Nuclear MutationsApplication 62706758Pending
  • Plastid-transgene-encoded nuclear gene silencingApplication 63351575Pending
  • Plastid-transgene-encoded nuclear gene silencingApplication 63309804Pending
  • Plastid Transformation By Complementation Of Plastid MutationsApplication PCTUS2021048399Pending
  • Plastid Transformation By Complementation Of Nuclear MutationsApplication PCTUS2021048408Pending

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .